Engineering Nanocarriers for siRNA Delivery
The discovery of RNA interference has revitalized the long ongoing pursuit of gene therapy for the treatment of diseases. Nevertheless, despite promising results from experimental studies, there remains a pressing need for the development of nanocarriers that are clinically‐relevant, biocompatible,...
Saved in:
Published in | Small (Weinheim an der Bergstrasse, Germany) Vol. 7; no. 7; pp. 841 - 856 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY-VCH Verlag
04.04.2011
WILEY‐VCH Verlag |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The discovery of RNA interference has revitalized the long ongoing pursuit of gene therapy for the treatment of diseases. Nevertheless, despite promising results from experimental studies, there remains a pressing need for the development of nanocarriers that are clinically‐relevant, biocompatible, efficient, and that can be tailored to specific disease targets. This review surveys the broad spectrum of nanomaterials and their functional add‐ons, and aims to provide a guide towards engineering nanocarriers for effective siRNA delivery.
Nanomaterials for drug delivery: There is a pressing need for the development of nanocarriers that are clinically‐relevant, biocompatible, efficient, and that can be tailored to specific disease targets. This review surveys the broad spectrum of nanomaterials and their functional add‐ons, and aims to provide a guide towards engineering nanocarriers for effective siRNA delivery. |
---|---|
Bibliography: | istex:BB973F64944C1DB209E6A34A6DB335FB30628041 ArticleID:SMLL201001389 ark:/67375/WNG-GSJQ9FR4-0 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-2 ObjectType-Feature-2 |
ISSN: | 1613-6810 1613-6829 1613-6829 |
DOI: | 10.1002/smll.201001389 |